[1] |
Shaddox L M, Spencer W P, Velsko I M, et al.Localized aggressive periodontitis immune response to healthy and diseased subgingival plaque[J]. J Clin Periodontol, 2016, 43(9); 746-753.
|
[2] |
Gonzales J R.T- and B-cell subsets in periodontitis[J]. Periodontol 2000, 2015, 69(1); 181-200.
|
[3] |
Boyle W J, Simonet W S, Lacey D L.Osteoclast differentiation and activation[J]. Nature, 2003, 423(6937); 337-342.
|
[4] |
Ben J, Zhang Y, Zhou R, et al.Major vauLt protein reguLates class A scavenger receptor-mediated tumor necrosis factor-alpha synthesis and apoptosis in macrophages[J]. J Biol Chem, 2013, 288(27); 20076-20084.
|
[5] |
Rogers J E, Li F, Coatney D D, et al.Actinobacillus actinomycetemcomitans lipopolysaccharide-mediated experimental bone loss model for aggressive periodontitis[J]. J Periodontol, 2007, 78(3); 550-558.
|
[6] |
Guo S, Ni Y, Ben J, et al.Class A Scavenger Receptor Exacerbates Osteoclastogenesis by an Interleukin-6-Mediated Mechanism through ERK and JNK Signaling Pathways[J]. Int J Biol Sci, 2016, 12(10); 1155-1167.
|
[7] |
Chen W, Ma J, Zhu G, et al.Cbfbeta deletion in mice recapituLates cleidocranial dysplasia and reveals muLtiple functions of Cbfbeta required for skeletal development[J]. Proc Natl AcadSci USA, 2014, 111(23); 8482-8487.
|
[8] |
Wang W, Wang H, Zhou X, et al.Lymphatic Endothelial Cells Produce M-CSF, Causing Massive Bone Loss in Mice[J]. J Bone Miner Res, 2017, 32(5); 939-950.
|
[9] |
Zhou M, Guo S, Yuan L, et al.Blockade of LGR4 inhibits proliferation and odonto/osteogenic differentiation of stem cells from apical papillae[J]. J Mol Histol, 2017, 48(5-6); 389-401.
|
[10] |
Huang J, Wu C, Tian B, et al.Myricetin Prevents Alveolar Bone Loss in an Experimental Ovariectomized Mouse Model of Periodontitis[J]. Int J Mol Sci, 2016, 17(3); 422.
|
[11] |
Matsuda S, Movila A, Suzuki M, et al.A novel method of sampling gingival crevicuLar fluid from a mouse model of periodontitis[J]. J Immunol Methods, 2016, 438; 21-25.
|
[12] |
Chen L L, Yan J.Porphyromonas gingivalis lipopolysaccharide activated bone resorption of osteoclasts by inducing IL-1, TNF, and PGE[J]. Acta Pharmacol Sin, 2001, 22(7); 614-618.
|
[13] |
Baldridge D, Shchelochkov O, Kelley B, et al.Signaling pathways in human skeletal dysplasias[J]. Annu Rev Genomics Hum Genet, 2010, 11; 189-217.
|
[14] |
Kim J H, Kim E Y, Lee B, et al.The effects of LyciiRadicis Cortex on RANKL-induced osteoclast differentiation and activation in RAW 264.7 cells[J]. Int J Mol Med, 2016, 37(3); 649-658.
|
[15] |
Takayanagi H, Kim S, Koga T, et al.Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts[J]. Dev Cell, 2002, 3(6); 889-901.
|
[16] |
Teitelbaum S L, Ross F P.Genetic reguLation of osteoclast development and function[J]. Nat Rev Genet, 2003, 4(8); 638-649.
|
[17] |
Novack D V, Teitelbaum S L.The osteoclast: friend or foe?[J]. Annu Rev Pathol, 2008, 3; 457-484.
|
[18] |
Jeong B C, Kim J H, Kim K, et al.ATF3 moduLates calcium signaling in osteoclast differentiation and activity by associating with c-Fos and NFATc1 proteins[J]. Bone, 2017, 95; 33-40.
|
[19] |
Yu K, Yau Y H, Sinha A, et al.ModuLation of the VauLt Protein-Protein Interaction for Tuning of MolecuLar Release[J]. Sci Rep, 2017, 7(1); 14816.
|
[20] |
Ben J, Jiang B, Wang D, et al.Major vauLt protein suppresses obesity and atherosclerosis through inhibiting IKK-NF-kappaB signaling mediated inflammation[J]. Nat Commun, 2019, 10(1); 1801.
|